Drug Details |  |
| Name: | Velnacrine |  |
|---|
| PubChem ID: | 3655 |
|---|
| Pathway: | Show KEGG pathways |
|---|
| InChI: | InChI=1S/C13H14N2O/c14-13-8-4-1-2-5-9(8)15-10-6-3-7-11(16)12(10)13/h1-2,4-5,11,16H,3,6-7H2,(H2,14,15) |
|---|
| SMILES: | OC1CCCc2c1c(N)c1c(n2)cccc1 |
|---|
|
| Properties: | | Formula: | C13H14N2O | Atoms: | 16 |
|---|
| Molecular Weight: | 214.263 | Rotatable Bonds: | 0 |
|---|
| H-bond Acceptors: | 3 | H-bond Donors: | 2 |
|---|
| logP: | 2.7679 | | |
|---|
|
|---|
| Targets: | |
|---|
| Synonyms: | | ()-oxazepam hemisuccinate sodium salt | | 1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate | | 1,2,3,4-tetrahydro-9-aminoacridine-1-ol | | 1-Acridinol, 9-amino-1,2,3,4-tetrahydro- | | 1-hydroxytacrine | | 104675-29-8 | | 112964-98-4 | | 121445-17-8 | | 124027-47-0 | | 9-amino-1,2,3,4-tetrahydroacridin-1-ol | | 9-ATHCO | | AB00053578 | | AC1L1GF2 | | AC1Q7AWG | | AKOS001642124 | | AN-907/25060019 | | AR-1H5421 | | BPBio1_000546 | | BRD-A98299281-050-04-7 | | BSPBio_000496 | | BSPBio_003296 | | C056424 | | C13H14N2O | | CCG-204673 | | CHEBI:179946 | | CHEMBL51934 | | DivK1c_000577 | | HMS2089F15 | | HP 029 | | HP-029 | | Hydroxytacrine maleate | | IDI1_000577 | | KBio1_000577 | | KBio2_000473 | | KBio2_003041 | | KBio2_005609 | | KBio3_002516 | | KBioGR_001329 | | KBioSS_000473 | | Lopac0_000584 | | LS-171934 | | MolPort-000-000-925 | | NCGC00015506-03 | | NCGC00015506-04 | | NCGC00162194-01 | | NCGC00162194-02 | | NINDS_000577 | | Oprea1_439874 | | Prestwick3_000448 | | SPBio_001030 | | Spectrum2_001215 | | Spectrum3_001708 | | Spectrum4_000815 | | Spectrum5_001267 | | Spectrum_000073 | | VeInacrine Maleate (+-) | | Velnacrina | | Velnacrina [INN-Spanish] | | Velnacrine | | velnacrine maleate | | Velnacrine [INN:BAN] | | Velnacrinum | | Velnacrinum [INN-Latin] |
|
|---|
